[Causes and consequences of glycated hemoglobin variability on pediatric population]

Maria Inês Santos1, Catarina Resende, Frederico Rosário

  • 1Consulta de Diabetologia Infantil, Serviço de Pediatria, Hospital de São Teotónio, Viseu, Portugal.

Insights

Adolescents and children with longer duration of type one diabetes mellitus show higher hemoglobin A1c (HbA1c) levels. Poor metabolic control in pediatric diabetes can lead to microalbuminuria and lipid disorders.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Type one diabetes mellitus is a prevalent childhood disease with severe complications if poorly managed.
  • Hemoglobin A1c (HbA1c) is the key indicator for metabolic control, and understanding its variability is crucial.

Purpose of the Study:

  • To assess the impact of age and disease duration on HbA1c levels in pediatric patients.
  • To investigate the correlation between HbA1c, serum lipid profiles, and microalbuminuria.

Main Methods:

  • An observational, cross-sectional, and analytical study was conducted.
  • Data from pediatric diabetic consultations were analyzed, including patient demographics, disease duration, metabolic control, and complications.
  • Statistical analysis was performed using Excel 2003 and SPSS 15.0 with a 5% significance level.

Main Results:

  • Adolescents exhibited significantly higher HbA1c (8.4%) compared to younger children (7.8%).
  • Patients with diabetes exceeding five years had elevated HbA1c (9%) versus those with shorter duration (7.8%).
  • Microalbuminuria (9%) and dyslipidemia (10%) were observed, with significantly higher HbA1c in affected patients (9.7% and 10% respectively).

Conclusions:

  • Increased HbA1c levels are associated with adolescence and longer disease duration in pediatric type one diabetes.
  • Complications like microalbuminuria and dyslipidemia are evident even in pediatric patients with suboptimal metabolic control.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.